Trial Profile
Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Patients Undergoing Laparoscopic Gastric Bypass Surgery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms CURES
- 30 Apr 2015 New trial record